Otsing - TalTech teadusportaal

Publikatsioonid
Profiilid
Uurimisrühmad
Registrid
Abi ja info
Switch to English

Publikatsioonid

Publikatsioonid

Otsing

Valitud kirjed 0

anti-GBM disease (võtmesõna)

—

—

—

—

Lisa tingimus Liitotsing filter

Tühista

teaviku laadid

raamat ..

artikkel ajakirjas ..

artikkel ajalehes ..

artikkel kogumikus ..

dissertatsioon ..

Open Access ..

Teaduspublikatsioon ..

aasta

Toon andmeid..

Toon andmeid..

TTÜ struktuuriüksus

Toon andmeid..

Toon andmeid..

Toon andmeid..

Toon andmeid..

Toon andmeid..

Tühista

Kirjeid leitud 3
Vaata veel.. (5/112)
Ekspordi

ekspordi kõik päringu tulemused (3)
Salvesta TXT fail

prindi
Märgitud kirjetega toimetamiseks ava valitud kirjed

kuva

reasta
1

artikkel ajakirjas EST / artikkel ajakirjas ENG

Endopeptidase cleavage of anti-glomerular basement membrane antibodies in vivo in severe kidney disease : an open-label phase 2a studyUhlin, Nils Fredrik Arne; Szpirt, Wladimir; Kronbichler, Andreas; Bruchfeld, Annette; Soveri, Inga; Rostaing, Lionel; Daugas, Eric; Lionet, Arnaud; Kamar, Nassim; Rafat, CedricJournal of the American Society of Nephrology2022 / p. 829-838 https://doi.org/10.1681/ASN.2021111460 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

artikkel ajakirjas EST / artikkel ajakirjas ENG
2

artikkel ajakirjas EST / artikkel ajakirjas ENG

The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane diseaseSoveri, Inga; Molne, Johan; Uhlin, Nils Fredrik Arne; Nilsson, Thomas; Kjellman, Christian; Sonessonm, Elisabeth; Segelmark, MartenKidney International2019 / p. 1234-1238 https://doi.org/10.1016/j.kint.2019.06.019 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

artikkel ajakirjas EST / artikkel ajakirjas ENG
3

artikkel ajakirjas EST / artikkel ajakirjas ENG

Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatmentTyrberg, Linnea; Andersson, Fanny; Uhlin, Nils Fredrik Arne; Hellmark, Thomas; Segelmark, MartenNephrology Dialysis Transplantation2024 / p. 45-54 https://doi.org/10.1093/ndt/gfad132 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

artikkel ajakirjas EST / artikkel ajakirjas ENG

Kirjeid leitud 3, kuvan 1 - 3

1. anti-GBM disease
2. Alzheimer’s disease
3. Alzheimer's disease
4. autoantibody-mediated renal disease
5. autosomal dominant polycystic kidney disease
6. cardiovascular disease
7. celiac disease
8. cerebrovascular disease
9. chronic kidney disease
10. chronic kidney disease (CKD)
11. chronic obstructive pulmonary disease
12. coronary artery disease
13. coronary artery disease (CAD)
14. coronary disease
15. coronary heart disease
16. disease
17. disease diagnosis
18. disease model
19. disease models
20. disease progression
21. disease resistance
22. disease-modifying therapy
23. End stage kidney disease
24. end stage renal disease
25. end-stage kidney disease
26. end-stage renal disease
27. garment workers and patients with occupational disease
28. gas bubble disease
29. genetic predisposition to disease
30. heart disease risk factors
31. human disease
32. Huntington’s disease
33. infectious disease
34. in-transit disease
35. late blight disease
36. loco-regionally metastatic disease
37. lyme disease
38. mechanisms of disease
39. Menkes disease
40. Metabolic dysfunction-associated steatotic liver disease
41. molecular bases of disease
42. NAFLD (non-alcoholic fatty liver disease)
43. neurodegenerative disease
44. neuromuscular disease
45. non-alcoholic fatty liver disease
46. oat striate and red disease
47. Parkinson disease
48. Parkinson’s disease
49. Parkinson’s disease machine learning
50. Parkinson's disease
51. physical overload disease
52. preclinical Alzheimer disease
53. renal disease
54. stable coronary heart disease
55. stereotypy of disease
56. subclinical cardiovascular disease
57. Wilson disease
58. Wilson’s disease
59. von Willebrand disease
60. anti-abuse
61. anti-abuse rule
62. anti-armor mine
63. anti-bacterial agents
64. anti-CD20 monoclonal antibodies
65. anti-competitive agreement
66. anti-H1N1 antibodies
67. anti-lock braking system
68. anti–lock braking system
69. anti-money laundering
70. anti-money laundering (AML)
71. anti-monotonicity
72. Anti-Muslim prejudice
73. anti-oxidant content
74. anti-oxidative activity
75. anti-P2X4 mAb
76. anti-quorum sensing
77. Anti-Str. uberis antibodies
78. Anti-TrustRank
79. general anti-abuse rule

1. Alber, Anti
2. Allikvee, Anti
3. Gruno, Anti
4. Haavajõe, Anti
5. Hamburg, Anti
6. Kalda, Anti
7. Kuiv, Anti
8. Kukkela, Anti
9. Kuus, Anti
10. Liiv, Anti
11. Liiva, Anti
12. Look, Anti
13. Naulainen, Anti
14. Palmi, Anti
15. Rohumaa, Anti
16. Ronk, Anti
17. Saar, Anti
18. Sullin, Anti
19. Viikna, Anti

1. Haavajõe, Anti
2. Hamburg, Anti
3. Haugas, Anti
4. Kuiv, Anti
5. Perkson, Anti
6. Puusepp, Anti, 1969-
7. Siinmaa, Anti
8. Viikna, Anti, 1944-2023

1. Alber, Anti
2. Haavajõe, Anti
3. Hamburg, Anti
4. Rohumaa, Anti
5. Viikna, Anti 1944-2023

1. European Anti-Fraud Office

vaste

reasta

Otsing
Valikud 0

ilmumisaasta

autor

TTÜ struktuuriüksus

märksõna

seeria-sari

tema kohta

võtmesõna

TalTech Raamatukogu

Akadeemia tee 1

13519

TalTech koduleht TalTech Raamatukogu koduleht Digikogu Digiteek Teadusandmed

6203551

data@taltech.ee

TalTech Raamatukogu